中性粒细胞对瘤免疫力和免疫疗法耐药性的影响,以及潜在的机制
Jiali Yao1, Linlin Ji1, Guang Wang1
1Clinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai, China.
Cancer communications (London, England)
|November 1, 2024
概括
中性粒细胞显著影响癌症的发展和免疫疗法耐药性. 向中性粒细胞提供了有希望的策略来克服治疗耐药性并改善癌症免疫治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 中性粒细胞是关键的免疫细胞,参与瘤发育和免疫逃避.
- 新出现的证据强调了中性粒细胞在癌症免疫疗法耐药性中的作用.
研究的目的:
- 为中性粒细胞分类,表型及其与瘤代谢,微生态,神经内分泌系统和治疗的相互作用提供一个新的视角.
- 审查癌症免疫疗法中中性粒细胞介导抗性的机制.
- 通过向中性粒细胞提出克服免疫疗法耐药性的策略.
主要方法:
- 在癌症中对中性粒细胞进行当前研究的文献综述和综合.
- 分析中性粒细胞在瘤免疫微环境中的作用,瘤抗原和表观遗传学.
- 确定针对中性粒细胞的潜在治疗策略.
主要成果:
- 中性粒细胞表现出不同的表型,影响癌症的进展和免疫逃避.
- 中性粒细胞通过调节免疫微环境,瘤抗原和表观遗传因素,促进免疫疗法耐药性.
- 向中性粒细胞是一种可行的方法,可以提高癌症免疫疗法的疗效.
结论:
- 了解中性粒细胞异质性和功能对于癌症免疫疗法至关重要.
- 针对中性粒细胞的策略在克服治疗耐药性方面具有显著的前景.
- 对中性粒细胞向治疗的进一步研究是有必要的,以改善患者的治疗结果.
更多相关视频
14:04Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
15.2K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
5.9K
相关概念视频
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
